Yikun Li

机构：Shandong University, Nantong University · ORCID：0000-0002-2117-8057

发表论文 50 篇 · 总被引 1093 次 · h-index 17

代表论文

• Noninvasive radiomic biomarkers for predicting pseudoprogression and hyperprogression in patients with non-small cell lung cancer treated with immune checkpoint inhibition (2024 · OncoImmunology · 被引 24)
• Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19 (2022 · Frontiers in Pharmacology · 被引 15)
• Development and validation of an MRI-Based nomogram to predict the effectiveness of immunotherapy for brain metastasis in patients with non-small cell lung cancer (2024 · Frontiers in Immunology · 被引 9)
• Computed Tomography‐Based Radiomics and Genomics Analyses for Survival Prediction of Stage III Unresectable Non‐Small Cell Lung Cancer Treated With Definitive Chemoradiotherapy and Immunotherapy (2025 · Molecular Carcinogenesis · 被引 8)
• Hydrogen sulfide sustains mitochondria functions via targeting mitochondria fission regulator 1 like protein to restore human cytotrophoblast invasion and migration (2025 · International Journal of Biological Macromolecules · 被引 7)
• A US case-control study to estimate infant group B streptococcal disease serological thresholds of risk-reduction (2025 · Nature Communications · 被引 6)